17-7627574-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_133491.5(SAT2):c.62T>G(p.Ile21Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000617 in 1,458,382 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133491.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 247676Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133940
GnomAD4 exome AF: 0.00000617 AC: 9AN: 1458382Hom.: 0 Cov.: 33 AF XY: 0.00000689 AC XY: 5AN XY: 725246
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.62T>G (p.I21S) alteration is located in exon 1 (coding exon 1) of the SAT2 gene. This alteration results from a T to G substitution at nucleotide position 62, causing the isoleucine (I) at amino acid position 21 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at